Pioglitazone Hydrochloride Tablet
Product Images NDC 50090-6386

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pioglitazone Hydrochloride (NDC 50090-6386). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500906386)

FDA Label Image

Figure 1 Shows The Time Course For Changes In Hba1c In This 26-week Study (Pioglitazone Fig1)

Figure 1 Shows The Time Course For Changes In Hba1c In This 26-week Study (Pioglitazone Fig1)
The figure shows the mean change in HbAlc from baseline in a 26-week placebo-controlled dose-ranging study for three different doses (15 mg, 30 mg, and 45 mg). The observed values are plotted over time (in weeks) and suggest that as the dose increases, there is a greater reduction in HbAlc.*
FDA Label Image

Chemical Structure (Pioglitazone Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.